Business Standard

Health ministry okays remdesivir, HCQ to treat Covid-19 under authorisation

In the new set of protocols, the ministry has removed its earlier recommendation of using hydroxychloroquine in combination with azithromycin in severe cases

Medics prepare to collect samples for swab tests from a COVID-19 mobile testing van, during the nationwide lockdown to curb the spread of coronavirus, at Ramakrishna Mission area in New Delhi. (PTI Photo/Manvender Vashist)
Premium

Medics prepare to collect samples for swab tests from a COVID-19 mobile testing van, during the nationwide lockdown to curb the spread of coronavirus, at Ramakrishna Mission area in New Delhi. (PTI Photo)

Press Trust of India New Delhi
The Union Health Ministry has recommended use of anti-viral drug remdesivir under emergency use authorisation, off-label application of immunomodulator tocilizumab and convalescent plasma therapy for treating Covid-19 patients in moderate stage of criticality.

Backtracking from its earlier stance, the ministry in its revised 'Clinical Management Protocols for Covid-19', released on Saturday, said anti-malarial drug hydroxychloroquine (HCQ) should be used in the early course of the disease to achieve any meaningful effect and should be avoided in severe cases.

In the new set of protocols, the ministry has removed its earlier recommendation of using hydroxychloroquine in combination with azithromycin in severe

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 13 2020 | 6:05 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com